Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added above the site navigation, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:58:33.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message, replacing the study details with an error screen while the site chrome remains visible. This indicates restricted access to the page's primary content.
    Difference
    17%
    Check dated 2026-09-23T00:53:51.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, upgrading from v3.6.6 to v3.7.0 to reflect a content refresh.
    Difference
    0.0%
    Check dated 2026-09-16T00:21:08.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.6 was added, replacing the previous v3.6.5, indicating a minor backend/template update.
    Difference
    0.0%
    Check dated 2026-09-01T19:47:38.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The NIH grant/contract year 2017 was added to the study identifiers. This supplements the existing EudraCT number with funding context for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:44:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.